RiverVest Venture Partners Names Pharmaceutical Veteran Bradley Keller as Entrepreneur-in-Residence
ST. LOUIS (May 13, 2013) – RiverVest Venture Partners announced today that Bradley Keller, Ph.D. has joined the life sciences venture capital firm as an Entrepreneur-in-Residence. (more…)
RiverVest Venture Partners’ O’Donnell Named to Experts Advisory Panel at Stevenage Bioscience Catalyst
ST. LOUIS (March 26, 2013) – RiverVest Venture Partners’ Principal Niall O’Donnell, Ph.D., has been invited to serve on the Experts Panel at Stevenage Bioscience Catalyst, the U.K.’s first open innovation bioscience campus focused on driving early-stage biotech, pharma and medtech developments. (more…)
Rady Venture Fund Develops Next Generation Tech Investors
SAN DIEGO, March 20, 2013 /PRNewswire-USNewswire/ — The Rady School of Management’s student-run venture capital fund, the Rady Venture Fund, has participated in a $16 million Series B raise in startup Savara Pharmaceuticals, which is developing an inhalable antibiotic to treat cystic fibrosis patients with lung infections. (more…)
RiverVest Venture Partners’ Returns More than Double Other Top Healthcare Venture Funds
ST. LOUIS (March 12, 2013) – RiverVest Venture Partners announced today that its Fund II has delivered a return of more than double that of a respected benchmark that delineates top-performing venture capital funds. (more…)
Karen Spilizewski to Speak on Venture Capital Panel At NASVF Annual Conference
Aug. 24, 2012 – CLEVELAND – Rivervest’s Karen Spilizewski is scheduled to join other entrepreneurial luminaries when she speaks at the 2012 National Association for Seed and Venture Funds (NASVF) Conference. Keynote speakers include Steve Case, TechStars’ Katie Rae and Open Table’s Chuck Templeton, who are all scheduled to address this year’s theme: “Advancing Innovation: Seeding Tomorrow’s Opportunities.” (more…)
St. Louis Revs Its Start Up Engine
Once a major headquarters town, the Gateway City is becoming more entrepreneurial….Read More
RiverVest Advisory Board Member William A. Peck, MD, Receives Prestigious Award at Washington University in St. Louis
May 5, 2012 – William A. Peck, MD, the Alan A. and Edith L. Wolff Distinguished Professor of Medicine and director of the Center for Health Policy at Washington University in St. Louis, was presented with the Washington University Eliot Society “Search” Award at the 45th annual dinner of the William Greenleaf Eliot Society May 1 at the Ritz-Carlton Hotel in Clayton, Mo. Read more
St. Louis Business Journal “Another Payday for RiverVest”
March 16, 2012 – A $1 billion-plus deal between Boston Scientific Corp. and medical device firm Cameron Health Inc. is bringing a payout of more than $12 million to RiverVest Venture Partners and its investors. Read More
RiverVest Venture Partners’ Medical Device Pioneer Sold to Boston Scientific
March 9, 2012 – ST. LOUIS , MO- RiverVest Venture Partners today announced that Boston Scientific Corporation has exercised its option to acquire RiverVest portfolio company Cameron Health, Inc., a medical device innovator based in San Clemente, California. (more…)
RiverVest Venture Partners’ Karen Spilizewski to Speak at Biomedical MEMS and Sensors 2012
March 8, 2012 – ST. LOUIS, MO & CLEVELAND, OH – RiverVest Venture Partners today announced that RiverVest V.P. Karen Spilizewski will speak at BioMEMS 2012’s Venture Capital session on March 22.
The conference will focus on MEMS technologies for biomedical applications, or BioMEMS, whose market size is estimated at $1.7 billion. BioMEMS, or the biological and biomedical applications of micro- and nanotechnology, is finding widespread applicability and uses in areas such as diagnostics, therapeutics and tissue engineering. (more…)